Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children

Francesca Raimondi1, Franck Iserin1, Olivier Raisky1

  • 1Centre de Référence Malformations Cardiaques Congénitales Complexes-M3C, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker-Enfants Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France.

Insights

Myocardial inflammation detected by cardiac magnetic resonance (CMR) in children with dilated cardiomyopathy predicts left ventricular (LV) function recovery. This finding highlights CMR

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Imaging
  • Inflammatory Heart Disease

Background:

  • Dilated cardiomyopathy (DCM) in children can lead to significant morbidity.
  • Assessing myocardial inflammation is crucial for predicting outcomes in pediatric DCM.
  • Cardiac magnetic resonance (CMR) offers advanced imaging capabilities for evaluating heart conditions.

Purpose of the Study:

  • To investigate the predictive value of myocardial inflammation, identified via CMR, for the recovery of left ventricular (LV) function in children recently diagnosed with DCM.
  • To determine if CMR findings correlate with clinical outcomes and recovery of LV function.

Main Methods:

  • A cohort of 66 children with newly diagnosed DCM underwent CMR within two weeks of diagnosis.
  • CMR utilized sequences sensitive to edema, hyperemia, and irreversible injury, including T2-weighted and late gadolinium-enhanced (LGE) imaging.
  • Myocardial inflammation was defined by the presence of at least two CMR criteria; patients were categorized as CMR-positive or CMR-negative.

Main Results:

  • 31 out of 66 children were classified as CMR-positive for myocardial inflammation.
  • Left ventricular (LV) function recovery was significantly more frequent in the CMR-positive group (24/31) compared to the CMR-negative group (11/33).
  • Myocardial inflammation (OR 3.76) and elevated troponin levels (OR 2.76) were significant predictors of LV function recovery.

Conclusions:

  • Myocardial inflammation identified by CMR at the time of diagnosis is a strong predictor of LV functional recovery in pediatric dilated cardiomyopathy.
  • CMR assessment of inflammation can aid in risk stratification and management decisions for children with DCM.
  • The absence of LGE in CMR-negative patients suggests a favorable prognosis regarding irreversible myocardial injury.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
622
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
468
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
330
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
920